Pharmaceutical Executive March 24, 2025
The latest news for pharma industry insiders.
PAP 2025: Boosting Patient Empowerment
The presentation suggests ways to educate patients on the options available to them, with the hope of ultimately improving health outcomes.
Email Remains a Leading Security Risk in Healthcare
It was found that Microsoft 365 was the most frequently compromised platform, responsible for 43.3% of breaches.
Alnylam Heart Drug Approval Sets Up Challenge With Pfizer
Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old biotech — if it can beat out stiff competition from the likes of Pfizer Inc.
Johnson & Johnson Increases U.S. Investment to More than $55 Billion Over the Next Four Years
Johnson...